0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Iloprost Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-2P9510
Home | Market Reports | Health| Pharmacy
Global Iloprost Drugs Market Size Status and Forecast 2022
BUY CHAPTERS

Global Iloprost Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-2P9510
Report
July 2025
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Iloprost Drugs Market Size

In 2024, the global market size of Iloprost Drugs was estimated to be worth US$ 87.2 million and is forecast to reach approximately US$ 78 million by 2031 with a CAGR of -1.6% during the forecast period 2025-2031.

Iloprost Drugs Market

Iloprost Drugs Market

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud"s phenomenon and other diseases in which the blood vessels are constricted and blood can"t flow to the tissues.
North America is estimated to have a major share in the global market with 75%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Iloprost Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iloprost Drugs.
The Iloprost Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Iloprost Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iloprost Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Iloprost Drugs Market Report

Report Metric Details
Report Name Iloprost Drugs Market
Forecasted market size in 2031 approximately US$ 78 million
Forecasted years 2025 - 2031
Segment by Type
  • Inhaled
  • Intravenous
Segment by Application
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Actelion (J & J), Bayer AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Iloprost Drugs in global and regional level.
  • Chapter 3: Detailed analysis of Iloprost Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Iloprost Drugs revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Iloprost Drugs Market size in 2031?

Ans: The Iloprost Drugs Market size in 2031 will be approximately US$ 78 million.

What is the Iloprost Drugs Market share by region?

Ans: North America is estimated to have a major share in the global market with 75%.

Who are the main players in the Iloprost Drugs Market report?

Ans: The main players in the Iloprost Drugs Market are Actelion (J & J), Bayer AG

What are the Application segmentation covered in the Iloprost Drugs Market report?

Ans: The Applications covered in the Iloprost Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the Iloprost Drugs Market report?

Ans: The Types covered in the Iloprost Drugs Market report are Inhaled, Intravenous

1 Study Coverage
1.1 Iloprost Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Iloprost Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Inhaled
1.2.3 Intravenous
1.3 Market by Application
1.3.1 Global Iloprost Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Iloprost Drugs Market Size Estimates and Forecasts
2.2 Iloprost Drugs Market Size by Region: 2024 Versus 2031
2.2.1 Global Iloprost Drugs Revenue by Region: 2020-2025
2.2.2 Global Iloprost Drugs Revenue Forecast by Region (2026-2031)
2.2.3 Global Iloprost Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Iloprost Drugs Revenue by Type (2020-2031)
3.1.2 Global Iloprost Drugs Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Iloprost Drugs Revenue by Application (2020-2031)
3.2.2 Global Iloprost Drugs Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Inhaled of Iloprost Drugs Revenue Market Share by Application
3.3.2 Intravenous of Iloprost Drugs Revenue Market Share by Application
4 Global Iloprost Drugs by Company
4.1 Global Iloprost Drugs Revenue by Company (2020-2025)
4.2 Global Iloprost Drugs Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Iloprost Drugs Companies around the World: Ranking by Revenue
4.3.2 Global Iloprost Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Iloprost Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Iloprost Drugs Companies Headquarters & Product Type
4.4.1 Global Iloprost Drugs Companies Headquarters
4.4.2 Date of International Companies Enter into Iloprost Drugs Market
4.4.3 Global Iloprost Drugs Companies Product & Service
4.4.4 Inhaled Revenue Market Share of Iloprost Drugs by Company
4.5 Global Iloprost Drugs Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Actelion (J & J)
5.1.1 Actelion (J & J) Corporation Information
5.1.2 Actelion (J & J) Description, Business Overview
5.1.3 Actelion (J & J) Iloprost Drugs Products Offered
5.1.4 Actelion (J & J) Iloprost Drugs Revenue and Gross Margin (2020-2025)
5.1.5 Actelion (J & J) Iloprost Drugs Revenue by Product in 2024
5.1.6 Actelion (J & J) Iloprost Drugs Revenue by Application in 2024
5.1.7 Actelion (J & J) Iloprost Drugs Revenue by Geographic Area in 2024
5.1.8 Actelion (J & J) Recent Developments
5.2 Bayer AG
5.2.1 Bayer AG Corporation Information
5.2.2 Bayer AG Description, Business Overview
5.2.3 Bayer AG Iloprost Drugs Products Offered
5.2.4 Bayer AG Iloprost Drugs Revenue and Gross Margin (2020-2025)
5.2.5 Bayer AG Iloprost Drugs Revenue by Product in 2024
5.2.6 Bayer AG Iloprost Drugs Revenue by Application in 2024
5.2.7 Bayer AG Iloprost Drugs Revenue by Geographic Area in 2024
5.2.8 Bayer AG Recent Developments
6 North America
6.1 North America Iloprost Drugs Market Size YoY Growth 2020-2031
6.2 North America Iloprost Drugs Market Facts & Figures by Country (2020-2031)
6.3 North America Iloprost Drugs Revenue by Type (2020-2025)
6.4 North America Iloprost Drugs Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Iloprost Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Iloprost Drugs Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Iloprost Drugs Revenue by Type (2020-2025)
7.4 Asia-Pacific Iloprost Drugs Revenue by Application (2020-2025)
8 Europe
8.1 Europe Iloprost Drugs Market Size YoY Growth 2020-2031
8.2 Europe Iloprost Drugs Market Facts & Figures by Country (2020-2031)
8.3 Europe Iloprost Drugs Revenue by Type (2020-2025)
8.4 Europe Iloprost Drugs Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Iloprost Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Iloprost Drugs Market Facts & Figures by Country (2020-2031)
9.3 Latin America Iloprost Drugs Revenue by Type (2020-2025)
9.4 Latin America Iloprost Drugs Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Iloprost Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Iloprost Drugs Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Iloprost Drugs Revenue by Type (2020-2025)
10.4 Middle East and Africa Iloprost Drugs Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Iloprost Drugs Supply Chain Analysis
11.2 Iloprost Drugs Key Raw Materials and Upstream Suppliers
11.3 Iloprost Drugs Clients Analysis
11.4 Iloprost Drugs Sales Channel and Sales Model Analysis
11.4.1 Iloprost Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Iloprost Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Iloprost Drugs Distributors
12 Iloprost Drugs Market Dynamics
12.1 Iloprost Drugs Industry Trends
12.2 Iloprost Drugs Market Drivers
12.3 Iloprost Drugs Market Challenges
12.4 Iloprost Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Iloprost Drugs Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Iloprost Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Iloprost Drugs Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Iloprost Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Iloprost Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Iloprost Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Iloprost Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Iloprost Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Iloprost Drugs Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Iloprost Drugs Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Iloprost Drugs Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Iloprost Drugs Players by Revenue (US$ Million) in 2024
 Table 13. Global Iloprost Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Iloprost Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iloprost Drugs as of 2024)
 Table 15. Global Iloprost Drugs Companies Headquarters
 Table 16. Date of International Companies Enter into Iloprost Drugs Market
 Table 17. Global Iloprost Drugs Companies Product & Service
 Table 18. Global Iloprost Drugs Mergers & Acquisitions, Expansion Plans
 Table 19. Actelion (J & J) Corporation Information
 Table 20. Actelion (J & J) Description and Business Overview
 Table 21. Actelion (J & J) Iloprost Drugs Product
 Table 22. Actelion (J & J) Iloprost Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Actelion (J & J) Revenue Proportion of Iloprost Drugs by Product in 2024
 Table 24. Actelion (J & J) Revenue Proportion of Iloprost Drugs by Application in 2024
 Table 25. Actelion (J & J) Revenue Proportion of Iloprost Drugs by Geographic Area in 2024
 Table 26. Actelion (J & J) Recent Developments
 Table 27. Bayer AG Corporation Information
 Table 28. Bayer AG Description and Business Overview
 Table 29. Bayer AG Iloprost Drugs Product
 Table 30. Bayer AG Iloprost Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Bayer AG Revenue Proportion of Iloprost Drugs by Product in 2024
 Table 32. Bayer AG Revenue Proportion of Iloprost Drugs by Application in 2024
 Table 33. Bayer AG Revenue Proportion of Iloprost Drugs by Geographic Area in 2024
 Table 34. Bayer AG Recent Developments
 Table 35. North America Iloprost Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 36. North America Iloprost Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 37. North America Iloprost Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 38. North America Iloprost Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Iloprost Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Iloprost Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Iloprost Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Iloprost Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 43. Europe Iloprost Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Europe Iloprost Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Europe Iloprost Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 46. Europe Iloprost Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 47. Latin America Iloprost Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 48. Latin America Iloprost Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 49. Latin America Iloprost Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 50. Latin America Iloprost Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 51. Middle East and Africa Iloprost Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 52. Middle East and Africa Iloprost Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 53. Middle East and Africa Iloprost Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 54. Middle East and Africa Iloprost Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 55. Iloprost Drugs Key Raw Materials, Industry Status and Trend
 Table 56. Iloprost Drugs Key Raw Materials and Upstream Suppliers
 Table 57. Iloprost Drugs Clients Status and Trend
 Table 58. Iloprost Drugs Typical Clients
 Table 59. Iloprost Drugs Distributors
 Table 60. Iloprost Drugs Market Trends
 Table 61. Iloprost Drugs Market Drivers
 Table 62. Iloprost Drugs Market Challenges
 Table 63. Iloprost Drugs Market Restraints
 Table 64. Research Programs/Design for This Report
 Table 65. Key Data Information from Secondary Sources
 Table 66. Key Data Information from Primary Sources


List of Figures
 Figure 1. Iloprost Drugs Product Picture
 Figure 2. Global Iloprost Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Iloprost Drugs Revenue Market Share by Type in 2024 & 2031
 Figure 4. Inhaled Product Picture
 Figure 5. Intravenous Product Picture
 Figure 6. Global Iloprost Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Iloprost Drugs Revenue Market Share by Application in 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Iloprost Drugs Report Years Considered
 Figure 11. Global Iloprost Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Iloprost Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Iloprost Drugs Market Size Market Share by Region: 2024 Versus 2031
 Figure 14. Global Iloprost Drugs Revenue Market Share by Region (2020-2031)
 Figure 15. Global Iloprost Drugs Revenue Market Share Forecast by Type (2020-2031)
 Figure 16. Global Iloprost Drugs Revenue Market Share Forecast by Application (2020-2031)
 Figure 17. Inhaled of Iloprost Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 18. Intravenous of Iloprost Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 19. Iloprost Drugs Revenue Share by Company (2024)
 Figure 20. Iloprost Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Inhaled Revenue Proportion by Company in 2024
 Figure 22. Intravenous Revenue Proportion by Company in 2024
 Figure 23. North America Iloprost Drugs Revenue 2020-2031 (US$ Million)
 Figure 24. North America Iloprost Drugs Revenue Market Share by Type (2020-2025)
 Figure 25. North America Iloprost Drugs Revenue Market Share by Application (2020-2025)
 Figure 26. Asia-Pacific Iloprost Drugs Revenue 2020-2031 (US$ Million)
 Figure 27. Asia-Pacific Iloprost Drugs Revenue Market Share by Region (2020-2031)
 Figure 28. Asia-Pacific Iloprost Drugs Revenue Market Share by Type (2020-2025)
 Figure 29. Asia-Pacific Iloprost Drugs Revenue Market Share by Application (2020-2025)
 Figure 30. Europe Iloprost Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 31. Europe Iloprost Drugs Revenue Market Share by Country (2020-2031)
 Figure 32. Europe Iloprost Drugs Revenue Market Share by Type (2020-2025)
 Figure 33. Europe Iloprost Drugs Revenue Market Share by Application (2020-2025)
 Figure 34. Latin America Iloprost Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 35. Latin America Iloprost Drugs Revenue Market Share by Country (2020-2031)
 Figure 36. Latin America Iloprost Drugs Revenue Market Share by Type (2020-2025)
 Figure 37. Latin America Iloprost Drugs Revenue Market Share by Application (2020-2025)
 Figure 38. Middle East and Africa Iloprost Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Middle East and Africa Iloprost Drugs Revenue Market Share by Country (2020-2031)
 Figure 40. Middle East and Africa Iloprost Drugs Revenue Market Share by Type (2020-2025)
 Figure 41. Middle East and Africa Iloprost Drugs Revenue Market Share by Application (2020-2025)
 Figure 42. Iloprost Drugs Supply Chain (Upstream and Downstream Market)
 Figure 43. Global Production Market Share of Iloprost Drugs Raw Materials by Region in 2024
 Figure 44. Iloprost Drugs Distribution Channels
 Figure 45. Global Iloprost Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 46. Global Iloprost Drugs Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 47. Bottom-up and Top-down Approaches for This Report
 Figure 48. Data Triangulation
 Figure 49. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart